| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |